The failure to follow good manufacturing practices leads to product defects, contamination, and other problems that put patients at risk.
List of drugs that "when medically needed in acute care must be available and used within hours or days of the need or the patient may suffer serious outcomes which may include disability or death." Check the dashboards for the most recent shortages, or at the complete PDF list, updated every week.
Get Resilient Drug Supply updates in your inbox.
Though downstream disruptions affected naloxone access, upstream supply has been solid.
The review recommends investment in innovative manufacturing and greater FDA authority.
IQVIA's 5-year forecast estimates the pandemic's effects on the global pharmaceutical market.
Experts outline pre-COVID-19 problems and spell out key steps to take.
Researchers estimate Canada's potential demand for tocilizumab, a potential COVID-19 drug.
Vaccines are just one of many COVID-disrupted services, a recent survey notes.
Should studies show COVID-19 effectiveness, fluvoxamine's supply chain looks resilient, an expert says.
In spite of an increase in days of supply, data still show discontinuation of some drugs.
Operation Warp Speed halted Tepezza manufacturing, but supplies of the drug will return this month.
The WHO and its partners will assess shortages of raw materials like plastic, glass, stoppers, and vials.
